KARA RICHEY: Open Payments
NPI 1710525035 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 10 payments from 7 companies in 2025. Trend: 2023 $286 · 2024 $523 · 2025 $1,044
Speaker / faculty: $788Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $871 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| PFIZER INC. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $32 |
| ABBVIE INC. | 1 | $28 |
| Genmab U.S., Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: Vyloy, IMBRUVICA, Epkinly, KEYTRUDA, OPDIVO, WELIREG, INLYTA, XTANDI.
Industry payments across OH — which companies pay providers there.
